BioCatalystFeed / Readout calendar / FDA decisions / Drugs / Disease areas / Companies / Months
SVA upcoming catalysts
Sinovac Biotech Co., Ltd: 3 upcoming industry Phase 2/3 trial readout(s) in the next 90 days (3 Phase 3), 0 upcoming FDA decision event(s), and in the last 12 months 8 readout(s) and 0 FDA event(s). Subscribe to SVA (.ics).
Drugs: Verorab®, experimental vaccine, Rabies Vaccine, Freeze-dried, Rabies vaccine
Upcoming FDA decision events
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No upcoming PDUFA date or AdCom found. | |||||
Upcoming trial readouts
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-12-30 est. | P3 | Sinovac Biotech Co., Ltd SVA | NCT07055295 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Regimen | Rabies | not yet recruiting | 390 |
| 2027-01 est. | P3 | Sinovac Biotech Co., Ltd SVA | NCT07505836 Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months | Epidemic Meningitis; Meningococcal Vaccines | recruiting | 1040 |
| 2027-01-30 est. | P3 | Sinovac Biotech Co., Ltd SVA | NCT07055893 Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Prophylaxis Regimen | Rabies (Healthy Volunteers) | not yet recruiting | 390 |
FDA decision events, last 12 months
| Date | Event | Status | Company | Drug | Source |
|---|---|---|---|---|---|
| No FDA decision events in this window. | |||||
Trial readouts, last 12 months
| Readout | Phase | Sponsor | Trial | Conditions | Status | Enrollment |
|---|---|---|---|---|---|---|
| 2026-11 est. | P3 | Sinovac Biotech Co., Ltd SVA | NCT07505888 Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years | Epidemic Meningitis; Meningococcal Vaccines | active not recruiting | 660 |
| 2026-07-15 | P3 | Sinovac Biotech Co., Ltd SVA | NCT07416110 Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine | Rabies (Healthy Volunteers) | active not recruiting | 912 |
| 2026-06-26 | P3 | Sinovac Biotech Co., Ltd SVA | NCT07211152 Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women | Influenza | completed | 150 |
| 2026-05-31 est. | P1/P2 | Sinovac Biotech Co., Ltd SVA | NCT07400003 Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine | Herpes Zoster; mRNA Vaccine | recruiting | 519 |
| 2026-01-15 est. | P2 | Sinovac Biotech Co., Ltd SVA | NCT07055880 Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell) | Rabies | not yet recruiting | 120 |
| 2025-12-30 | P1/P2 | Sinovac Biotech Co., Ltd SVA | NCT06754384 Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell). | Hand, Foot, and Mouth Disease (HFMD); Herpangina | completed | 552 |
| 2025-12-19 | P1/P2 | Sinovac Biotech Co., Ltd SVA | NCT06063057 Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial | Hand, Foot and Mouth Disease; Herpangina | completed | 744 |
| 2025-11-30 est. | P3 | Sinovac Biotech Co., Ltd SVA | NCT06734832 Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell) | Hand, Foot, and Mouth Disease(HFMD) | recruiting | 8000 |
Readout = ClinicalTrials.gov primary completion date (sponsor-reported; est. dates often slip; top-line
results usually follow weeks to months later). FDA events: PDUFA dates are extracted from company 8-K filings (SEC EDGAR) and are
company-disclosed and UNVERIFIED - read the filing; AdCom meetings come from Federal Register notices; approvals from Drugs@FDA
(openFDA); complete response letters from openFDA (published with a lag). Tickers are matched by name with a confidence score.
Generated 2026-11-18T17:57:33Z. Same data: bcf readouts search, bcf fda-decisions search, MCP
readout_calendar / fda_decisions. Not investment advice.